Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Nov 15, 2016
Dr. Peter Bach, Director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, endorsed delinkage approaches, particularly in the area of orphan drugs, at an October 21, 2016 forum hosted by Partnership for Quality Care (PQC) at the Kaiser Permanent Total Health Center in Washington, D.C.